BIOEQUIVALENCE BETWEEN INNOVATOR AND GENERIC TACROLIMUS IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED, CROSSOVER CLINICAL TRIAL.

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.

BACKGROUND:Although the generic drug approval process has a long-term successful track record, concerns remain for approval of narrow therapeutic index generic immunosuppressants, such as tacrolimus, in transplant recipients.Several professional transplant societies and publications have generated skepticism of the generic approval process.Three ma

read more

Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.

Human adenoid cystic carcinoma (ACC) is characterized by diffused invasion of the tumor into adjacent organs and early distant metastasis.Anoikis resistance and epithelial mesenchymal transition (EMT) are considered prerequisites for cancer cells to metastasize.Exploring the relationship between these processes and their underlying mechanism of act

read more